Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017
Thu, November 2, 2017
Wed, November 1, 2017
Tue, October 31, 2017
Mon, October 30, 2017
Fri, October 27, 2017

David Lewis Maintained (ZBH) at Buy with Decreased Target to $136 on, Nov 2nd, 2017


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-136-on-nov-2nd-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $146 to $136 on, Nov 2nd, 2017.

David has made no other calls on ZBH in the last 4 months.



There are 4 other peers that have a rating on ZBH. Out of the 4 peers that are also analyzing ZBH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Friday, July 28th, 2017


These are the ratings of the 3 analyists that currently disagree with David


  • Jennie Tsai of "Gabelli & Co." Initiated at Strong Buy on, Thursday, August 24th, 2017
  • Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Friday, July 28th, 2017
  • Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017

Publication Contributing Sources